Medtronic (MDT) Reports In-Line Q3 EPS; Guides Q4 In-Line
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 rises; Apple and Palantir set to report results
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mail
Get Alerts MDT Hot Sheet
Price: $98.97 +2.52%
Revenue Growth %: +5.3%
Financial Fact:
Net sales: 4.32B
Today's EPS Names:
LTBR, AES, SYRS, More
Revenue Growth %: +5.3%
Financial Fact:
Net sales: 4.32B
Today's EPS Names:
LTBR, AES, SYRS, More
Join SI Premium – FREE
Medtronic (NYSE: MDT) reported Q3 EPS of $1.37, in-line with the analyst estimate of $1.37. Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.94 billion.
GUIDANCE:
Medtronic sees Q4 2022 EPS of $1.56-$1.58, versus the consensus of $1.58. The company expects fourth quarter organic revenue growth of approximately 5.5%, in line with current fourth quarter organic revenue growth Street consensus.
For earnings history and earnings-related data on Medtronic (MDT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Marriott (MAR) Tops Q3 EPS by 19c; Guides EPS Higher
- Dominion Energy (D) Tops Q3 EPS by 9c, Beats on Revenue; Offers FY26 EPS Guidance
- Public Service Enterprise (PEG) Misses Q3 EPS by 4c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
